148 related articles for article (PubMed ID: 16354246)
1. Sirolimus: its role in nephrology.
Lee VW; Chapman JR
Nephrology (Carlton); 2005 Dec; 10(6):606-14. PubMed ID: 16354246
[TBL] [Abstract][Full Text] [Related]
2. The role and value of sirolimus administration in kidney and liver transplantation.
Mehrabi A; Fonouni H; Kashfi A; Schmied BM; Morath Ch; Sadeghi M; Schemmer P; Encke J; Sauer P; Zeier M; Weitz J; Büchler MW; Schmidt J
Clin Transplant; 2006; 20 Suppl 17():30-43. PubMed ID: 17100699
[TBL] [Abstract][Full Text] [Related]
3. [Nephrotoxicity of sirolimus: experimental and clinical data].
Pallet N; Thervet E; Legendre C; Anglicheau D
Nephrol Ther; 2006 Sep; 2(4):183-90. PubMed ID: 16966063
[TBL] [Abstract][Full Text] [Related]
4. [Use of Sirolimus in five pediatric patients undergoing solid organ transplantation].
Roque E J; Ríos M G; Vignolo A P; Pinochet V C; Schultz M; Humeres A R; Delucchi A; Rius A M; Hepp K J
Rev Med Chil; 2008 May; 136(5):631-6. PubMed ID: 18769812
[TBL] [Abstract][Full Text] [Related]
5. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.
Gaber AO; Kahan BD; Van Buren C; Schulman SL; Scarola J; Neylan JF;
Transplantation; 2008 Nov; 86(9):1187-95. PubMed ID: 19005398
[TBL] [Abstract][Full Text] [Related]
6. Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial.
Schena FP; Pascoe MD; Alberu J; del Carmen Rial M; Oberbauer R; Brennan DC; Campistol JM; Racusen L; Polinsky MS; Goldberg-Alberts R; Li H; Scarola J; Neylan JF;
Transplantation; 2009 Jan; 87(2):233-42. PubMed ID: 19155978
[TBL] [Abstract][Full Text] [Related]
7. Comparison of sirolimus and everolimus in their effects on blood lipid profiles and haematological parameters in heart transplant recipients.
Tenderich G; Fuchs U; Zittermann A; Muckelbauer R; Berthold HK; Koerfer R
Clin Transplant; 2007; 21(4):536-43. PubMed ID: 17645716
[TBL] [Abstract][Full Text] [Related]
8. Sirolimus--challenging current perspectives.
Buhaescu I; Izzedine H; Covic A
Ther Drug Monit; 2006 Oct; 28(5):577-84. PubMed ID: 17038868
[TBL] [Abstract][Full Text] [Related]
9. Considerations in sirolimus use in the early and late post-transplant periods.
Patel SJ; Elliott EN; Knight RJ; Gaber LW; Gaber AO
Expert Opin Drug Saf; 2009 Jul; 8(4):421-34. PubMed ID: 19522662
[TBL] [Abstract][Full Text] [Related]
10. Management of side effects of sirolimus therapy.
Stallone G; Infante B; Grandaliano G; Gesualdo L
Transplantation; 2009 Apr; 87(8 Suppl):S23-6. PubMed ID: 19384183
[TBL] [Abstract][Full Text] [Related]
11. Sirolimus monotherapy in liver transplantation.
Di Benedetto F; Di Sandro S; De Ruvo N; Masetti M; Montalti R; Romano A; Guerrini GP; Ballarin R; De Blasiis MG; Gerunda GE
Transplant Proc; 2007; 39(6):1930-2. PubMed ID: 17692656
[TBL] [Abstract][Full Text] [Related]
12. Conversion to sirolimus in pediatric renal transplantation recipients.
Garcia CD; Bittencourt VB; Alves AB; Garcia VD; Tumelero A; Antonello JS; Malheiros D
Transplant Proc; 2006; 38(6):1901-3. PubMed ID: 16908317
[TBL] [Abstract][Full Text] [Related]
13. Clinical application of sirolimus in renal transplantation: an update.
Chueh SC; Kahan BD
Transpl Int; 2005 Mar; 18(3):261-77. PubMed ID: 15730485
[TBL] [Abstract][Full Text] [Related]
14. Replacement of calcineurin-inhibitors with sirolimus as primary immunosuppression in stable cardiac transplant recipients.
Raichlin E; Khalpey Z; Kremers W; Frantz RP; Rodeheffer RJ; Clavell AL; Edwards BS; Kushwaha SS
Transplantation; 2007 Aug; 84(4):467-74. PubMed ID: 17713429
[TBL] [Abstract][Full Text] [Related]
15. Sirolimus for solid organ transplantation in children.
Gupta P; Kaufman S; Fishbein TM
Pediatr Transplant; 2005 Jun; 9(3):269-76. PubMed ID: 15910380
[TBL] [Abstract][Full Text] [Related]
16. Tolerance profile of the proliferation signal inhibitors everolimus and sirolimus in heart transplantation.
Moro JA; Almenar L; Martínez-Dolz L; Sánchez-Lázaro I; Agüero J; Salvador A
Transplant Proc; 2008 Nov; 40(9):3034-6. PubMed ID: 19010183
[TBL] [Abstract][Full Text] [Related]
17. Proteinuria after conversion to sirolimus in renal transplant recipients.
Sahin GM; Sahin S; Kantarci G; Ergin H
Transplant Proc; 2006 Dec; 38(10):3473-5. PubMed ID: 17175308
[TBL] [Abstract][Full Text] [Related]
18. mTOR inhibitors: an overview.
Neuhaus P; Klupp J; Langrehr JM
Liver Transpl; 2001 Jun; 7(6):473-84. PubMed ID: 11443573
[TBL] [Abstract][Full Text] [Related]
19. Sirolimus-based immunosuppressive therapy in liver transplant recipient with tacrolimus-related chronic renal insufficiency.
Yang YJ; Chen DZ; Li LX; Kou JT; Lang R; Jin ZK; Han DD; He Q
Transplant Proc; 2008 Jun; 40(5):1541-4. PubMed ID: 18589147
[TBL] [Abstract][Full Text] [Related]
20. The effect of sirolimus in the development of chronic allograft nephropathy.
Gürkan A; Kaçar S; Erdoğdu U; Varilsüha C; Kandemir G; Karaca C; Akman F
Transplant Proc; 2008; 40(1):114-6. PubMed ID: 18261561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
